ABBOTT LABORATORIES Loss Contingency, Estimate of Possible Loss
ABBOTT LABORATORIES (ABT) had Loss Contingency, Estimate of Possible Loss of $0 as of 2025-09-30, per its 10-Q filed 2025-10-29.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LossContingencyEstimateOfPossibleLoss · last filed 2025-10-29
- 2025-09-30: Loss Contingency, Estimate of Possible Loss $0.00.
- 2025-06-30: Loss Contingency, Estimate of Possible Loss $0.00.
- 2011-12-31: Loss Contingency, Estimate of Possible Loss $1.50B.
- 2011-09-30: Loss Contingency, Estimate of Possible Loss $1.50B.
| Period end | Loss Contingency, Estimate of Possible Loss |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-29 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-30 |
| 2011-12-31 | $1.50B 10-K · filed 2012-02-21 |
| 2011-09-30 | $1.50B 10-Q · filed 2011-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |